Your browser doesn't support javascript.
loading
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
Wang, Zhang; Singh, Richa; Miller, Bruce E; Tal-Singer, Ruth; Van Horn, Stephanie; Tomsho, Lynn; Mackay, Alexander; Allinson, James P; Webb, Adam J; Brookes, Anthony J; George, Leena M; Barker, Bethan; Kolsum, Umme; Donnelly, Louise E; Belchamber, Kylie; Barnes, Peter J; Singh, Dave; Brightling, Christopher E; Donaldson, Gavin C; Wedzicha, Jadwiga A; Brown, James R.
Afiliação
  • Wang Z; Computational Biology, Target Sciences, Research and Development (R&D), GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Singh R; National Heart and Lung Institute, Imperial College London, London, UK.
  • Miller BE; Respiratory Therapy Area Unit, R&D, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
  • Tal-Singer R; Respiratory Therapy Area Unit, R&D, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
  • Van Horn S; Target and Platform Validation, Target Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Tomsho L; Target and Platform Validation, Target Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Mackay A; National Heart and Lung Institute, Imperial College London, London, UK.
  • Allinson JP; National Heart and Lung Institute, Imperial College London, London, UK.
  • Webb AJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
  • Brookes AJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
  • George LM; Institute for Lung Health, University of Leicester, Leicester, UK.
  • Barker B; Institute for Lung Health, University of Leicester, Leicester, UK.
  • Kolsum U; Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital of South Manchester, Manchester, UK.
  • Donnelly LE; National Heart and Lung Institute, Imperial College London, London, UK.
  • Belchamber K; National Heart and Lung Institute, Imperial College London, London, UK.
  • Barnes PJ; National Heart and Lung Institute, Imperial College London, London, UK.
  • Singh D; Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital of South Manchester, Manchester, UK.
  • Brightling CE; Institute for Lung Health, University of Leicester, Leicester, UK.
  • Donaldson GC; National Heart and Lung Institute, Imperial College London, London, UK.
  • Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK.
  • Brown JR; Computational Biology, Target Sciences, Research and Development (R&D), GlaxoSmithKline, Collegeville, Pennsylvania, USA.
Thorax ; 73(4): 331-338, 2018 04.
Article em En | MEDLINE | ID: mdl-29269441

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escarro / Veillonella / Doença Pulmonar Obstrutiva Crônica / Microbiota / Moraxella Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Thorax Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escarro / Veillonella / Doença Pulmonar Obstrutiva Crônica / Microbiota / Moraxella Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Thorax Ano de publicação: 2018 Tipo de documento: Article